scholarly journals The Role of Exercise in Chemotherapy-Induced Peripheral Neuropathy

Author(s):  
Karen Y. Wonders ◽  
Brittany Stout
2021 ◽  
pp. 135941
Author(s):  
Megan L. Uhelski ◽  
Yan Li ◽  
Miriam M. Fonseca ◽  
E. Alfonso Romero-Snadoval ◽  
Patrick M. Dougherty

2010 ◽  
Vol 4 (2) ◽  
pp. 117-125 ◽  
Author(s):  
Karen Y. Wonders ◽  
Beverly S. Reigle ◽  
Daniel G. Drury

Toxicology ◽  
2019 ◽  
Vol 413 ◽  
pp. 33-39 ◽  
Author(s):  
Shiori Tomita ◽  
Fumiko Sekiguchi ◽  
Tomoyo Deguchi ◽  
Takaya Miyazaki ◽  
Yuya Ikeda ◽  
...  

2018 ◽  
Vol 55 (1) ◽  
pp. 52-61 ◽  
Author(s):  
Zunzhong Li ◽  
Yanshan Li ◽  
Qinghua Li ◽  
Zhenchun Zhang ◽  
Li Jiang ◽  
...  

BMJ ◽  
1964 ◽  
Vol 2 (5420) ◽  
pp. 1290-1292 ◽  
Author(s):  
J. Fennelly ◽  
O. Frank ◽  
H. Baker ◽  
C. M. Leevy

1983 ◽  
Vol 104 (4_Suppl) ◽  
pp. S89-S94
Author(s):  
E. Matikainen ◽  
J. Juntunen

ABSTRACT. Peripheral neuropathy is a frequent complication of diabetes mellitus. Alterations of the peripheral nervous system in diabetics have been studied in numerous investigations. There are many factors known to participate in the development of this complication, e.g. the age of the patient, duration of the diabetes, quality of the diabetic control etc. The role of different types of diabetes in development of neuropathy is still largely unclear since investigations on this aspect are few. It seems, however, that peripheral neuropathy in type 2 (non-insulin dependent) diabetes is common but often mild. The differential diagnosis of the peripheral neuropathy in type 2 diabetics is more difficult than in type 1 (insulin dependent) diabetics, since these patients tend to be older and also may have other concomitant disorders. In this paper the clinical features and pathogenetic mechanisms of neuropathy in type 2 diabetes are briefly discussed.


Sign in / Sign up

Export Citation Format

Share Document